Cancellation of state registration. Fosavans

August 02, 2016
Trade names:
ICD-10:
XIII.M80-M85.M80    Osteoporosis with pathological fracture
XIII.M80-M85.M81.0    Postmenopausal osteoporosis
XIII.M80-M85.M81.1    Osteoporosis after removal of ovaries
Fosavans, osteoporosis, menopause, pathological fracture in osteoporosis, ovarian excision, postmenopause

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ dated 12.04.2010 "On circulation of medicines", decided to abolish the stateregistration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate LSR-002619/07 dated 07.09.2007, issued by Merck Sharp and Doum BV, Netherlands):

Fosavans (trade name of the medicinal product)

Alendronic acid +Kolekaltsiferol (international non-proprietary or chemical name of the medicinal product)

tablets, 70 mg + 70 μg (dosage form, dosage)

Merck Sharp and Doum BV, Netherlands Waarderweg 39, 2031 BN Haarlem, the Netherlands (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity of the company LLC "MSD Pharmaceuticals" to cancel the state registration of the medicinal product.